Stocks
GSK plcGSK
NYSEHealthcarePharmaceuticals$53.39-1.64%
A global pharmaceutical leader known for developing vaccines and prescription medicines, including treatments for respiratory diseases and HIV. Investors monitor GSK for its pipeline of innovative drugs and stable dividend payments.
Market Cap: $107.1B52W Range: $32.38 – $61.70
Congressional Interest in GSK plc (GSK)
18 members of Congress have disclosed 50 trades in GSK plc (GSK), a Healthcare company. The buy/sell breakdown shows 34 purchases versus 16 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
50
Unique Politicians
18
Buys
34
Sells
16
Who in Congress Is Trading GSK?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2020-02-12 | JANE HARMAN | buy | $1K – $15K |
| 2020-02-04 | David P. Roe | buy | $15K – $50K |